SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15044211
Source:
http://linkedlifedata.com/resource/pubmed/id/15044211
Search
Subject
(
74
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0038013
,
umls-concept:C0087111
,
umls-concept:C0243161
,
umls-concept:C1515273
,
umls-concept:C1527148
,
umls-concept:C1705313
,
umls-concept:C2003941
pubmed:issue
11
pubmed:dateCreated
2004-10-13
pubmed:abstractText
To develop and compare candidate improvement criteria for anti-TNFalpha treatment in ankylosing spondylitis with optimal discriminating capacity between treatment and placebo.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-10229426
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-10229432
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-10857793
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-11469469
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-11508441
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-11592375
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-11762956
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-11920412
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-11955536
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-11986408
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-12022358
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-12223105
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-12422001
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-12594105
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-12794835
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-7699630
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-7779114
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-7799351
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-9375888
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044211-9751088
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372355
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor
,
http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0003-4967
pubmed:author
pubmed-author:BrandtJJ
,
pubmed-author:BraunJJ
,
pubmed-author:ListingJJ
,
pubmed-author:RudwaleitMM
,
pubmed-author:SieperJJ
,
pubmed-author:van der HeijdeDD
pubmed:issnType
Print
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1438-44
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:15044211-Adult
,
pubmed-meshheading:15044211-Antibodies, Monoclonal
,
pubmed-meshheading:15044211-Chi-Square Distribution
,
pubmed-meshheading:15044211-Data Interpretation, Statistical
,
pubmed-meshheading:15044211-Female
,
pubmed-meshheading:15044211-Humans
,
pubmed-meshheading:15044211-Immunoglobulin G
,
pubmed-meshheading:15044211-Male
,
pubmed-meshheading:15044211-Middle Aged
,
pubmed-meshheading:15044211-Randomized Controlled Trials as Topic
,
pubmed-meshheading:15044211-Receptors, Tumor Necrosis Factor
,
pubmed-meshheading:15044211-Spondylitis, Ankylosing
,
pubmed-meshheading:15044211-Treatment Outcome
,
pubmed-meshheading:15044211-Tumor Necrosis Factor-alpha
pubmed:year
2004
pubmed:articleTitle
Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis.
pubmed:affiliation
Department of Gastroenterology/Rheumatology, Charité, Berlin, Germany.
pubmed:publicationType
Journal Article
,
Evaluation Studies